What is eSMART
eSMART (e-Symptom Management using Advanced Symptom Management System Remote Technology) is a research project financed under the Seventh Framework Programme, coordinated by the University of Surrey. Τhe clinical trial aims to evaluate the impact of a mobile phone-based, remote monitoring, symptom management intervention (the Advanced Symptom Management System, ASyMS) on the delivery of care to people diagnosed with non metastatic breast, colorectal or haematological (NHL, HL) cancer during chemotherapy and for one year after the end of treatment.
eSMART involves 10 world renowed European and one American partner, among them seven Universities, University medical centers and a technology company. You may learn about any of the eSMART partners by selecting one and clicking on the link:
eSMART will be conducted across 17 sites in Europe (Greece, UK, Ireland, Austria, Norway) and 1108 cancer patients will be recruited.
eSmart will demonstrate how technology can be instrumental in the delivery of patient focused, anticipatory care that improves the outcomes and quality of life of cancer patients. It will demonstrate the effects of a real-time, mobile phone based, remote patient monitoring and care. The planned interventions will address key cancer patient symptoms and cancer care results and the delivery of care during and after chemotherapy. The remote patient monitoring system via mobile phone, i.e., the Advanced Symptom Management System (ASyMS), will help cancer patients reduce the symptom burden experienced during chemotherapy and improve their quality of life (QoL) during acute treatment and survivorship. Most important, the project results will facilitate changes in clinical practice thus, leading to improved delivery of cancer care.
Patients have a prominent co-researcher role in eSMART and participate in all project activities from project concept to implementation. ECPC, in its patient representative role participates equally with other researchers in the eSMART project in the Project Technical Management Board, in the Publications Committee, in the Exploitation Committee, offering advice and feedback to ensure that the trial is designed and conducted in line with patients’ needs and preferences.
You may read the latest eSmart news in the monthly Newsletter.
Information about eSMART